1. Home
  2. MRCC vs ME Comparison

MRCC vs ME Comparison

Compare MRCC & ME Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MRCC
  • ME
  • Stock Information
  • Founded
  • MRCC 2011
  • ME 2006
  • Country
  • MRCC United States
  • ME United States
  • Employees
  • MRCC N/A
  • ME N/A
  • Industry
  • MRCC Investment Managers
  • ME Precision Instruments
  • Sector
  • MRCC Finance
  • ME Health Care
  • Exchange
  • MRCC Nasdaq
  • ME Nasdaq
  • Market Cap
  • MRCC 174.8M
  • ME 98.7M
  • IPO Year
  • MRCC 2012
  • ME N/A
  • Fundamental
  • Price
  • MRCC $8.24
  • ME $3.39
  • Analyst Decision
  • MRCC Strong Buy
  • ME Hold
  • Analyst Count
  • MRCC 1
  • ME 1
  • Target Price
  • MRCC $9.00
  • ME $9.40
  • AVG Volume (30 Days)
  • MRCC 65.9K
  • ME 219.4K
  • Earning Date
  • MRCC 11-12-2024
  • ME 02-05-2025
  • Dividend Yield
  • MRCC 12.14%
  • ME N/A
  • EPS Growth
  • MRCC 298.01
  • ME N/A
  • EPS
  • MRCC 0.60
  • ME N/A
  • Revenue
  • MRCC $62,007,000.00
  • ME $193,260,000.00
  • Revenue This Year
  • MRCC N/A
  • ME $21.93
  • Revenue Next Year
  • MRCC N/A
  • ME $17.31
  • P/E Ratio
  • MRCC $13.73
  • ME N/A
  • Revenue Growth
  • MRCC N/A
  • ME N/A
  • 52 Week Low
  • MRCC $6.97
  • ME $2.66
  • 52 Week High
  • MRCC $8.80
  • ME $16.52
  • Technical
  • Relative Strength Index (RSI)
  • MRCC 46.26
  • ME 44.56
  • Support Level
  • MRCC $8.10
  • ME $3.15
  • Resistance Level
  • MRCC $8.80
  • ME $4.18
  • Average True Range (ATR)
  • MRCC 0.21
  • ME 0.26
  • MACD
  • MRCC -0.02
  • ME 0.05
  • Stochastic Oscillator
  • MRCC 23.29
  • ME 29.46

About MRCC Monroe Capital Corporation

Monroe Capital Corp is a speciality finance company focused on providing financing to lower middle-market companies, in the U.S. and Canada. The company provides customized financing solutions focused on senior, unitranche, and junior secured debt and unsecured subordinated debt and equity, including equity co-investments in preferred and common stock and warrants.

About ME 23andMe Holding Co.

23andMe Holding Co is a consumer-facing healthcare technology company, primarily involved in the sale of direct-to-consumer personal genome services, or PGS, through DNA collection kits shipped via mail. The company provides users access to reports summarizing estimated genetic ancestry breakdown, phenotypic trait reports, and various health predisposition and disease carrier reports. Its segment includes Consumer and Research Services and Therapeutics. The company generates maximum revenue from the Consumer and Research Services segment.

Share on Social Networks: